Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Molecules (Basel, Switzerland)|September 5, 2020
Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors-In Vitro, In Silico and QSAR StudiesRadoslav Chayrov, Nikolaos A Parisis, Maria V Chatziathanasiadou, et al.Dalton Transactions (Cambridge, England : 2003)|June 14, 2021
Development of novel GnRH and Tat48-60 based luminescent probes with enhanced cellular uptake and bioimaging profileAnastasia Kougioumtzi, Maria V Chatziathanasiadou, Eirinaios I Vrettos, et al.Journal of Biomolecular Structure & Dynamics|September 9, 2021
Molecular investigation of artificial and natural sweeteners as potential anti-inflammatory agentsEleni Chontzopoulou, Christina D Papaemmanouil, Maria V Chatziathanasiadou, et al.Amino Acids|May 21, 2018
Tailoring acyclovir prodrugs with enhanced antiviral activity: rational design, synthesis, human plasma stability and in vitro evaluationRadoslav L Chayrov, Evgenios K Stylos, Maria V Chatziathanasiadou, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|June 28, 2024
A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter-Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to GemcitabineEirinaios Ι Vrettos, Stavroula G Kyrkou, Vasiliki Zoi, et al.Biochimica Et Biophysica Acta. Biomembranes|March 10, 2017
Exploring the interactions of irbesartan and irbesartan-2-hydroxypropyl-β-cyclodextrin complex with model membranesΑdamantia S Liossi, Dimitrios Ntountaniotis, Tahsin F Kellici, et al.Molecular Pharmaceutics|September 28, 2020
Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery SystemsKonstantina Manta, Paraskevi Papakyriakopoulou, Maria Chountoulesi, et al.Molecular Pharmaceutics|January 26, 2019
Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II AntagonismDimitrios Ntountaniotis, Ioannis Andreadelis, Tahsin F Kellici, et al.Proceedings of the National Academy of Sciences of the United States of America|August 2, 2022
Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic strategy for glioblastomaRichard Perryman, Alexander Renziehausen, Hamidreza Shaye, et al.Pageof 3